Search by Ticker
Gilead Sciences (NASDAQ:GILD)
The following stock analysis is based on 7.5 years of data (i.e. since Feb 08, 2013). All the stock history has been downloaded.
Gilead Sciences trades on the NasdaqGS exchange in USD dollars.
It is in the sector.
It is currently trading at $69.35 ($68.81 the previous day).It pays a 3.81% dividend.
The next reporting date is in 74 days (2020 10 22).
CNN estimates profits for the upcoming quarter will be $1.99 per share ($6.5B). The current Canada / US exchange rate is 1.3382.
Over the past 12 months, $0 worth of shares have been purchased and $13658457 worth of shares have been sold by insiders.
The year over year average increase is -10.5% per year assuming steady exponential growth. The actual 5 year average is -7.64. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||68.908227272727||0.8||+ Above Average|
|2 year||68.331195219124||-10.3||- Below Average|
|3 year||76.147112970711||6.4||+ Above Average|
|4 year||71.557032520325||-24.3||- Below Average|
|5 year||94.469358490566||-10.8||- Below Average|
The worst drop it has had in recent years is -50.5%. It has a shape to the stock curve, which means
These Chip Stocks Jumped On Upbeat Earnings ReportsFri, 07 Aug 2020 20:23:24 Amid a mixed week for chip company earnings, two semiconductor stocks got a boost from beat-and-raise reports. SiTime and Synaptics cheered investors with their results and guidance.... Read Full Article
Pfizer to Produce Gilead Virus-Treatment Candidate RemdesivirFri, 07 Aug 2020 16:02:00 Pfizer signed a multi-year agreement to produce Gilead Sciencesand' coronavirus-treatment candidate remdesivir.... Read Full Article
Pfizer Will Help Gilead Sciences Make Its Covid-19 Treatment, RemdesivirFri, 07 Aug 2020 15:04:00 The drug giant is one of the firms that will manufacture remdesivir, Gilead Sciences’ experimental antiviral that got emergency approval in May as a treatment for Covid-19.... Read Full Article
Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug RemdesivirFri, 07 Aug 2020 14:07:29 Large-cap biopharma companies Pfizer Inc. (NYSE: PFE) and Gilead Sciences, Inc. (NASDAQ: GILD) announced a deal Friday for GIleadand's remdesivir, which has been accorded emergency use authorization by the FDA for treating COVID-19.The Pfizer-Gilead Partnership: Pfizer said it has ...... Read Full Article
NIH to test remdesivir with Merck KGaAand's interferon therapy as a COVID-19 treatmentFri, 07 Aug 2020 13:11:00 The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.and's remdesivir with Merck KGaAand's interferon beta-1a as a treatment for COVID-19 patients. The study plans to enroll 1,000 ...... Read Full Article
Pfizer to help manufacture Gileadand's remdesivirFri, 07 Aug 2020 12:10:00 Shares of Pfizer Inc. gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.and's COVID-19 treatment remdesivir as part of a multi-year agreement. Gileadand's stock was up 0.6% on Friday before the market ...... Read Full Article
Pfizer signs deal to supply Gileadand's remdesivir for COVID-19Fri, 07 Aug 2020 12:07:28 ... Read Full Article
UKand's Hikma starts manufacturing COVID-19 treatment remdesivir for GileadFri, 07 Aug 2020 08:00:12 Hikma Pharmaceuticals has started manufacturing remdesivir, an approved treatment for COVID-19 from U.S.-based Gilead, for an undisclosed amount at its facility in Portugal, the British company's chief executive officer said. The company will supply the first batches of ...... Read Full Article
Diodes Incorporated Reports Second Quarter 2020 Financial ResultsThu, 06 Aug 2020 20:05:00 Diodes Incorporated (Nasdaq: DIOD) today reported its financial results for the second quarter ended June 30, 2020.... Read Full Article
NIH to test Lillyand's experimental monoclonal antibody treatment in mild and moderate COVID-19 casesWed, 05 Aug 2020 11:58:00 Shares of Eli Lilly and Co. gained 0.6% in premarket trading on Wednesday, the day after the National Institutes of Health said it plans to study whether several experimental monoclonal antibodies can treat hospitalized COVID-19 patients. The first therapy to be ...... Read Full Article
Zydus Cadilaand's COVID-19 vaccine candidate found safe in early-stage human trialWed, 05 Aug 2020 06:00:58 India's Zydus Cadila said on Wednesday its COVID-19 vaccine candidate was found to be safe and well-tolerated in an early-stage human trial. The company will now start a mid-stage trial of the vaccine candidate, ZyCoV-D, in over 1,000 healthy adult volunteers ...... Read Full Article
State attorneys general urge U.S. to let other firms make Gilead COVID-19 drugWed, 05 Aug 2020 02:09:19 The coalition of more than 30 state attorneys general called on the government to act or allow states to do so, saying in a letter to U.S. health agencies that Gilead "has not established a reasonable price" for remdesivir. "Gilead ...... Read Full Article
NIH to launch trials to test antibody drugs for COVID-19Tue, 04 Aug 2020 17:35:21 ... Read Full Article
State attorneys general urge U.S. govt to increase supply, lower price of remdesivirTue, 04 Aug 2020 15:45:05 ... Read Full Article
Is Gilead Sciences a Buy After Its Disappointing Q2 Results?Tue, 04 Aug 2020 10:41:00 Gilead Sciences (NASDAQ: GILD) beat Wall Street estimates when the big biotech announced its first-quarter results in late April. Last week, Gilead announced second-quarter results that were below analysts' expectations. Gilead has been in the news quite a bit in ...... Read Full Article
Taiwan provisionally approves dexamethasone as coronavirus treatmentTue, 04 Aug 2020 08:26:42 Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the antiviral drug remdesivir after the United States bought nearly all global supplies. Taiwan Centres for ...... Read Full Article
Gilead Stock Is Rising Because Covid-Treatment Sales Could Top $3 BillionMon, 03 Aug 2020 16:46:00 Sales of its Covid-19 treatment could be worth more than $3 billion this year for Gilead Sciences, Citigroup’s Mohit Bansal says.... Read Full Article
Rival drugmakers launch joint trial of medicines for COVID-19Mon, 03 Aug 2020 09:45:00 Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused ...... Read Full Article
Better Buy: Gilead Sciences vs. PfizerSat, 01 Aug 2020 14:44:00 Gilead Sciences (NASDAQ: GILD) and Pfizer (NYSE: PFE) are two of the most competent pharmaceutical companies in the industry. Recently, Gilead has been in the headlines thanks to its much-discussed antiviral drug remdesivir, which appears to be somewhat beneficial for ...... Read Full Article
Gilead Sciences (GILD) Q2 2020 Earnings Call TranscriptSat, 01 Aug 2020 05:33:33 GILD earnings call for the period ending June 30, 2020.... Read Full Article